ALFA Finder| Revenue growth | 6.6% YoY consolidated; 36% QoQ growth. |
|---|---|
| Margins | Consolidated business EBITDA at 8.9% in Q4. |
| Demand visibility | Easing destocking in global accounts; recovery in Europe/India. |
| Management confidence | Confident in strategic rationale and long-term synergy targets. |
Growth
Q4 consolidated revenue grew 6.6% YoY and ~36% QoQ. Legacy Sudarshan EBITDA grew 21.6% YoY to 14.4% margin.
Outlook
FY27 guided sales ~€700Mn and EBITDA ~€35Mn for acquired group; 3-4 year EBITDA target of €90-100Mn.
Risks
Geopolitical uncertainty impacting logistics, rising raw material costs, and cautionary customer purchasing behavior.
Earnings Call filed with BSE, NSE: SUDARSCHEM. Summary written with AI assistance from the document.
Sudarshan Chemical Industries Ltd: key numbers
- Share price
- ₹1,168.35
- Market cap
- ₹9,304 Cr
- Revenue (annual)
- ₹9,787 Cr
- Net profit (annual)
- ₹22.30 Cr
- P/E (TTM)
- 105.4×Sector 35.5×
- Promoter holding
- 9.32%+1.13% QoQ
- FII holding
- 8.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sudarshan Chemical Industries Ltd
All →Sudarshan Chemical Industries Investor Presentation: Key Takeaways
Q2 FY27 One Sudarshan revenue ₹2,743 Cr (+14.9% YoY), business EBITDA ₹239 Cr (8.7% margin, +4.7pp). Integration progressing; VP4 sale completed 2 Nov 2026.
Sudarshan Chemical Industries Q2 FY27 Results: Net Profit ₹30.5 Cr, Up 58.0% YoY
Sudarshan Chemical Industries Ltd reported revenue from operations of ₹2,743 Cr (+14.9% YoY) and net profit of ₹30.5 Cr (+58.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹30.5 Cr · +58.0% YoY
Sudarshan Chemical Industries Board Meeting Date
Sudarshan Chemical schedules a 6 November 2026 board meeting to consider unaudited quarterly and half-year results. Trading window stays closed until 8 November 2026.
Sudarshan Chemical Industries Merger & Restructuring Worth ₹795.9 Cr
Sudarshan Chemical completed sale of VP4 Frankfurt GmbH to Celanese for about Rs 795.9 crore. VP4 Frankfurt is no longer a step-down subsidiary.
- Value
- ₹795.9 Cr
Sudarshan Chemical Industries Employee Stock Options
Sudarshan Chemical allotted 19,350 equity shares to employees exercising options under its 2018 ESOP plan. The allotment is at an exercise price of Rs 349.35 per share.
Sudarshan Chemical Industries Credit Rating
India Ratings has revised the outlook on Sudarshan Chemical Industries' debt facilities to Positive from Stable, while affirming the existing credit ratings.